EP Patent

EP3694590A1 — Drug delivery systems and related methods

Assigned to Pearl Therapeutics Inc · Expires 2020-08-19 · 6y expired

What this patent protects

Systems and methods for isolating and / or desiccating a portion of a drug delivery tract of a drug delivery apparatus to reduce the amount of water vapor within the drug delivery tract -this. For example, the invention relates to a metered dose inhaler for delivering an aerosol …

USPTO Abstract

Systems and methods for isolating and / or desiccating a portion of a drug delivery tract of a drug delivery apparatus to reduce the amount of water vapor within the drug delivery tract -this. For example, the invention relates to a metered dose inhaler for delivering an aerosol drug or other material to a user. The aerosol medication or other material may be evacuated from a discharge passage within the inhaler to an inhalation passageway for inhalation by a user, and the inhaler may include a sealing designed to selectively isolate the exhaust passage from the inhalation passage and the external environment during inactivity. The inhaler may further include a desiccant material disposed to remove moisture from the isolated discharge passage. In other cases, a desiccant material may be arranged to remove moisture from the inhaler vent passage without isolating the discharge passage during inactivity.

Drugs covered by this patent

Patent Metadata

Patent number
EP3694590A1
Jurisdiction
EP
Classification
Expires
2020-08-19
Drug substance claim
No
Drug product claim
No
Assignee
Pearl Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.